Inspire Financial Statements From 2010 to 2025
| 2DR Stock | EUR 180.25 2.10 1.15% |
Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
Inspire |
Inspire Medical Systems Company Current Valuation Analysis
Inspire Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Inspire Medical Current Valuation | 6.62 B |
Most of Inspire Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Inspire Medical Systems has a Current Valuation of 6.62 B. This is 53.93% lower than that of the Healthcare sector and 46.74% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 60.2% higher than that of the company.
Inspire Medical Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inspire Medical's current stock value. Our valuation model uses many indicators to compare Inspire Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inspire Medical competition to find correlations between indicators driving Inspire Medical's intrinsic value. More Info.Inspire Medical Systems is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inspire Medical's earnings, one of the primary drivers of an investment's value.About Inspire Medical Financial Statements
Inspire Medical stakeholders use historical fundamental indicators, such as Inspire Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Inspire Medical's assets and liabilities are reflected in the revenues and expenses on Inspire Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Inspire Medical Systems. Please read more on our technical analysis and fundamental analysis pages.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and Europe. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. INSPIRE MED operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 341 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inspire Stock
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:Check out the analysis of Inspire Medical Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.